Medical AI

An Oxford startup's AI-powered blood test can detect cancer and heart disease in dogs from a single sample, heralding a shift from reactive to proactive care.

A new company is launching an AI-powered specialty to detect cancer before it forms. But can this personalized, oncologist-led model overcome hurdles of cost and access?

The global MRI market is shifting from a hardware race to a software game. AI, low-helium systems, and workflow automation are the new keys to success.

The Association for Diagnostics & Laboratory Medicine's new leadership, led by Dr. Christina Lockwood, signals a decisive move to tackle healthcare's biggest challenges.

A new partnership between Harvard researchers and AI firm HiLabs aims to unmask the 'ghost networks' in Medicare Advantage, a crisis blocking care for millions.

GuideAI Health's new AI platform just hit the public market. It promises to find hidden vascular disease in routine scans, but can it navigate the risks?

An award for an AI search tool seems routine, but Ask Ella signals a deeper rewiring of the life sciences industry, turning data drudgery into strategic speed.

By combining vast datasets with patient-driven advocacy, a new alliance offers hope for angiosarcoma patients and a new model for rare disease research.

The animal health leader faces scrutiny in its Q2 earnings call after a rocky first quarter. All eyes are on its strategy to balance market pressures with future-focused bets.

A new deal in Israel signals a shift from noisy, ineffective warnings to precise, life-saving insights. Is this the future of personalized medication safety?

A new wearable from NeuroLife promises to personalize stroke and spinal cord injury rehab. Can this non-invasive sleeve bridge the gap in accessible care?

Health Union's new AI suite aims to connect patients and doctors. But can algorithms truly capture the human element of care without compromising privacy?

A new MS center in Lone Tree isn't just an expansion; it's a strategic play, blending clinical expertise with a powerful new operational model for growth.

Carolyn Starrett's appointment to the NeoGenomics board signals a major push to integrate AI and real-world data into the core of cancer diagnostics.

Aidoc's 'First Read' AI has earned a coveted FDA Breakthrough designation, promising to ease radiologist workload. But can an algorithm be trusted with your health?

UpDoc just secured the first FDA clearance for a patient-facing clinical AI. This isn't just another app; it's a new paradigm for healthcare delivery.

A projected 23% CAGR signals more than growth in digital health; it's a tectonic shift. We dissect the capital, tech, and players vying for market dominance.

With a key hire from Apple, a startup aims to move pet care beyond gadgets by building a clinically-backed AI system. But can it earn the trust of vets and owners?

A new app promises a 24/7 AI advocate for patients. But its real innovation may lie in its radical business model and a mission to tackle health inequality.

With a Wall Street veteran as CFO and a top cardiologist as advisor, Australian AI firm Echo IQ is executing a calculated assault on the U.S. healthcare market.